May 26, 2010 -- San Diego --
Volcano Corporation (NASDAQ: VOLC) announced today that it has
received CE Mark approval for the VIBE™ RX Vascular Imaging Balloon
Catheter. The company also announced that it has completed its
first clinical cases with the VIBE™ RX in New Zealand.
A single
VIBE™ RX Catheter can quickly access, prepare, and assess challenging
lesions. IVUS guidance provides precise, targeted balloon dilatation
with immediate confirmation of interventional results. |